| Literature DB >> 28874164 |
Kanishka Ratnayaka1,2, Joshua P Kanter3, Anthony Z Faranesh4, Elena K Grant4,3, Laura J Olivieri3, Russell R Cross3, Ileen F Cronin3, Karin S Hamann3, Adrienne E Campbell-Washburn4, Kendall J O'Brien4,3, Toby Rogers4, Michael S Hansen4, Robert J Lederman4.
Abstract
BACKGROUND: Children with heart disease may require repeated X-Ray cardiac catheterization procedures, are more radiosensitive, and more likely to survive to experience oncologic risks of medical radiation. Cardiovascular magnetic resonance (CMR) is radiation-free and offers information about structure, function, and perfusion but not hemodynamics. We intend to perform complete radiation-free diagnostic right heart catheterization entirely using CMR fluoroscopy guidance in an unselected cohort of pediatric patients; we report the feasibility and safety.Entities:
Keywords: Catheterization; Interventional Cardiovascular MRI; MRI fluoroscopy; Magnetic Resonance Imaging; Real-time MRI
Mesh:
Year: 2017 PMID: 28874164 PMCID: PMC5585983 DOI: 10.1186/s12968-017-0374-2
Source DB: PubMed Journal: J Cardiovasc Magn Reson ISSN: 1097-6647 Impact factor: 5.364
Fig. 1Patient enrollment
Fig. 2ICMR suite. CMR heart catheterization procedures were performed in an interventional CMR suite (Panel a) consisting of adjoining CMR room and biplane X-Ray fluoroscopy suite. The interventional cardiac MRI room is outfitted for invasive cardiac catheterization (Panels b, c). The patient and CMR scanner have sterile drapes. Operators observe sterile technique and wear noise-cancelling communication headsets. Commercially available passive catheters are connected to conventional pressure transducers that interface (panel b black box) with the commercial hemodynamic recording system. The room is equipped with commercial projectors that are shielded for CMR operation. Rear projected images show the commercial hemodynamic recording system (panel c, upper left), and real-time CMR console (panel c, lower left). Commercial hemodynamic monitor (panel c, upper right) and CMR host (panel c, lower right) are also shown
Demographics
| Characteristic | Finding |
|---|---|
| Age | 12.7 ± 4.7 |
| Gender | 51% Female |
| Height | 146.3 ± 23.7 |
| Weight | 48.8 ± 26.5 |
| Body surface area | 1.4 ± 0.5 |
| CMR RHC indication | |
| Transplant (%) | 33 |
| Shunt (%) | 28 |
| Pulmonary hypertension (%) | 18 |
| Cardiomyopathy (%) | 15 |
| Valvular heart disease (%) | 3 |
| Other (%) | 3 |
| History | |
| Prior cardiac surgery (%) | 44 |
| Prior cardiac catheterization (%) | 59 |
| 1 previous (%) | 8 |
| multiple previous (%) | 51 |
| if multiple, how many? | 5.5 ± 5 |
| Retained thoracic surgical or catheter device (%) | 36 |
| Continuous intravenous vasopressor (%) | 5 |
| Oral Medication (%) | 72 |
Fig. 3CMR right heart catheterization. Panels (a, b, and c) show real time CMR catheter navigation to superior vena cava (SVC), right ventricle (RV), and right pulmonary artery (RPA) respectively. Panels (d, e, and f) show the same respective imaging planes after flow-sensitive saturation preparation pulse to null blood pool. Gadolinium filled balloon (white arrow) is easily and often better (best represented in panel b versus panel e) visualized during this real-time black blood imaging
Procedural characteristics
| Procedural detail | Finding |
|---|---|
| CMR RHC procedure time: 1 condition (min; n = 40) | 12 ± 5 |
| CMR RHC procedure time: 2 conditions (min; n = 10) | 31 ± 10 |
| Total CMR scanner time (min) | 50 ± 14 |
| Additional research CMR imaging (%) | 66 |
| Additional clinical CMR imaging (%) | 15 |
| CMR RHC body temperature Δ (Celsius) | 0.3 ± 0.4 |
| CMR RHC catheters | |
| Medtronic (%) | 50 |
| Edwards "T" tip (%) | 40 |
| Arrow (%) | 20 |
| Edwards (%) | 8 |
| Edwards "S" tip (%) | 2 |
| Cook (%) | 0 |
| Vascor (%) | 0 |
| X-Ray procedure | |
| X-Ray procedure performed (%) | 80 |
| Fluoroscopy time (min) | 3.8 ± 3.8 |
| Dose Area Product (Gy∙cm2) | 1295.7 ± 2363 |
| Endomyocardial biopsy | 23 |
| Left heart catheterization | 9 |
| Shunt device closure | 10 |
| Coronary angiography | 11 |
| Thermodilution | 1 |
| Other | 3 |
Fig. 4CMR cardiac catheterization in patient with pulmonary artery stent imaging artifact. Panel (a) shows imaging artifact (circled) from previously placed pulmonary artery stents; CMR right heart catheterization was successful. Panel (b) shows oblique axial imaging plane showing branch pulmonary arteries (thick white arrow = stent imaging artifact). Panel (e) and (g) show oblique coronal imaging planes for right and left pulmonary artery respectively. Panels c (RPA = right pulmonary artery), d (LPA = left pulmonary artery), f (RPA), h (LPA) show the same respective imaging planes after flow-sensitive saturation preparation pulse to null blood pool. Gadolinium filled balloon is easily visualized during this real-time black blood imaging
Flow measurements using the Fick technique and using velocity encoded CMR
| Fick versus Phase Contrast in catheterizations without shunt ( | |
| Fick pulmonary blood flow (Qp, L/min/m2) | 3.3 ± 0.7 |
| Fick systemic blood flow (Qs, L/min/m2) | 3.3 ± 0.7 |
| Fick pulmonary: systemic blood flow (Qp:Qs) | 1 ± 0.1 |
| Fick pulmonary vascular resistance (indexed Woods units) | 2.4 ± 1.9 |
| Phase Contrast Main Pulmonary Artery indexed (Qp, L/min/m2) | 2.9 ± 0.6* |
| Phase Contrast Aorta indexed (Qs, L/min/m2) | 2.8 ± 0.6* |
| Phase Contrast pulmonary: systemic blood flow (Qp:Qs) | 1 ± 0.1 |
| Phase Contrast pulmonary vascular resistance (indexed Woods units) | 2.5 ± 2.1 |
| Fick versus Phase Contrast in catheterizations with shunt (n = 11) | |
| Fick pulmonary blood flow (Qp, L/min/m2) | 5.6 ± 2.1 |
| Fick systemic blood flow (Qs, L/min/m2) | 3.4 ± 0.8 |
| Fick pulmonary: systemic blood flow (Qp:Qs) | 1.8 ± 0.9 |
| Fick pulmonary vascular resistance (indexed Woods units) | 1.9 ± 1.6 |
| Phase Contrast Main Pulmonary Artery indexed (Qp, L/min/m2) | 5.1 ± 2.1 |
| Phase Contrast Aorta indexed (Qs, L/min/m2) | 2.8 ± 0.7* |
| Phase Contrast pulmonary: systemic blood flow (Qp:Qs) | 2 ± 0.9* |
| Phase Contrast pulmonary vascular resistance (indexed Woods units) | 2.1 ± 2 |
*p<0.05 Student t-test (two-tailed)
*p<0.05 Wilcoxon Signed Ranks Test (two-tailed)
Study subjects
| Subject number | Age (yr) | CMR RHC indication | # previous X-Ray Caths | Retained thoracic implant | CMR RHC time (min) |
|---|---|---|---|---|---|
| Subject 1 | 14.8 | Valvular heart disease | none | sternal wires | 19 |
| Subject 2 | 21.1 | Transplant | 15 | sternal wires | 13 |
| Subject 3 | 12.8 | Transplant | 14 | sternal wires | 19 |
| Subject 4 | 13.3 | Transplant | 13 | sternal wires | 12 |
| Subject 5 | 17.1 | Cardiomyopathyb | 2 | none | 48a |
| Subject 6 | 12.2 | Other | none | surgical clips, sternal wires | 29 |
| Subject 7 | 14.9 | Shunt (Atrial Septal Defect) | none | none | 18 |
| Subject 8 | 10 | Transplant | 2 | sternal wires | 6 |
| Subject 9 | 5.4 | Cardiomyopathyb | none | none | 12 |
| Subject 10 | 13.8 | Transplant | none | sternal wires | 8 |
| Subject 11 | 9.6 | Shunt (Atrial Septal Defect) | none | none | 11 |
| Subject 12 | 10.1 | Transplant | 2 | sternal wires | 12 |
| Subject 13 | 13.1 | Pulmonary hypertension | none | none | 45a |
| Subject 14 | 6.3 | Transplant | 8 | surgical clips, sternal wires, pulmonary artery stents, embolization coils | 18 |
| Subject 15 | 10.2 | Shunt (Atrioventricular Canal Defect) | 2 | none | 16 |
| Subject 16 | 18.8 | Shunt (Patent Ductus Arteriosus) | none | none | 9 |
| Subject 17 | 15.3 | Transplant | 2 | sternal wires | 18 |
| Subject 18 | 18.2 | Cardiomyopathy | none | none | 17 |
| Subject 19 | 15.2 | Transplant | 2 | sternal wires | 11 |
| Subject 20 | 4.4 | Shunt (Atrial Septal Defect) | none | none | 16 |
| Subject 21 | 16.6 | Transplant | 12 | sternal wires | 15 |
| Subject 22 | 15.8 | Cardiomyopathy | 3 | none | 15 |
| Subject 23 | 9.2 | Cardiomyopathy | 1 | none | 23a |
| Subject 24 | 17.3 | Transplant | 13 | sternal wires, temporary pacing wire | 9 |
| Subject 25 | 6.3 | Shunt (Patent Ductus Arteriosus) | none | none | 14 |
| Subject 26 | 12.5 | Shunt (Atrial Septal Defect) | none | none | 8 |
| Subject 27 | 17.5 | Transplant | 4 | surgical clips, sternal wires | 13 |
| Subject 28 | 13.9 | Shunt (Patent Ductus Arteriosus) | none | sternal wires | 16 |
| Subject 29 | 5 | Transplant | 5 | none | 10 |
| Subject 30 | 20.7 | Shunt (Atrial Septal Defect) | none | none | 15 |
| Subject 31 | 6.1 | Pulmonary hypertension | 3 | none | 27a |
| Subject 32 | 4.6 | Pulmonary hypertension | 2 | none | 25a |
| Subject 33 | 18 | Shunt (Atrial Septal Defect) | none | none | 9 |
| Subject 34 | 16 | Shunt (Atrial Septal Defect) | none | none | 11 |
| Subject 35 | 9.3 | Pulmonary hypertension | 5 | sternal wires | 21a |
| Subject 36 | 17.3 | Pulmonary hypertension | 1 | none | 25a |
| Subject 37 | 5.7 | Cardiomyopathy | 4 | none | 22a |
| Subject 38 | 14.9 | Pulmonary hypertension | 0 | none | 40a |
| Subject 39 | 13.1 | Pulmonary hypertension | 5 | none | 39a |
Subjects 3, 4, 10, 19, 21, 22: two MRI right heart catheterizations (MRI RHC); Subject 8: six MRI RHC [mean time shown]
aMultiple hemodynamic conditions tested in MRI RHC
bContinuous vasoactive infusion for poor myocardial function
Fig. 5Left heart CMR catheterization in patients with atrial septal defect and complete atrioventricular canal defect. Real-time CMR guided left heart catheterization in patients with atrial septal defect (panels a–d) and complete atrioventricular canal defect (panels e–h) are shown. Each two panel sequence (i.e., Panels a/b, etc.) are in the same imaging plane with standard real-time steady state free precession and after flow-sensitive saturation preparation pulse to null blood pool. Panel (b) shows the gadolinium filled balloon navigated from right atrium across the atrial septal defect to the right upper pulmonary vein (RUPV). Panel (d) shows the balloon navigated to the left ventricle (LV). Panel (f) shows the balloon in the left atrium (LA). Panel (h) shows the balloon after navigation to the left ventricle